Clinical trial
Study of Gemcitabine and Oxaliplatin With Radiation Therapy in Patients With…
NCT00456599 · University of Michigan Rogel Cancer Center, Other · Completed
Key facts
| NCT number | NCT00456599 |
|---|---|
| Title | Study of Gemcitabine and Oxaliplatin With Radiation Therapy in Patients With Pancreatic Cancer |
| Official title | A Multi-Institutional Phase II Study of Neoadjuvant Gemcitabine and Oxaliplatin With Radiation Therapy in Patients With Pancreatic Cancer |
| Lead sponsor | University of Michigan Rogel Cancer Center, Other |
| Collaborators | Sanofi Industry Johns Hopkins University Princess Margaret Hospital, Canada Ohio State University |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pancreatic Cancer |
| Intervention type | Drug, Procedure |
| Interventions | gemcitabine, oxaliplatin, Radiation |
| Enrollment | 71 |
| Start date | Apr 1, 2007 |
| Primary completion | May 1, 2012 |
| Completion | Jan 1, 2013 |
| First posted | Apr 5, 2007 |
| Last update posted | Dec 3, 2015 |
| Countries | Canada, United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: